Nicholas J. Pace net worth and biography

Nicholas Pace Biography and Net Worth

EVP of Owens & Minor

Executive Vice President, General Counsel and Corporate Secretary since May 2018. After joining Owens & Minor in 2016, Nick served as Senior Vice President, General Counsel & Corporate Secretary. He was promoted to Executive Vice President in May 2018. Prior to joining the company, Nick served as Executive Vice President, General Counsel & Secretary of Landmark Health, LLC from July-December 2015. From January 2014 to July 2015, he served in simultaneous roles of Senior Vice President, Strategy & General Counsel of Landmark Health, LLC and Executive Vice President, Corporate Development & General Counsel of Avalon Health Services, LLC, two healthcare companies sponsored by the private equity firm Francisco Partners. From March to October 2013, Nick served as Executive Vice President, Operations & Compliance for Health Diagnostic Laboratory, Inc. Prior to that role, he served as Executive Vice President, General Counsel & Secretary of Amerigroup Corporation, where he worked from 2006-2013.

How do I contact Nicholas J. Pace?: The corporate mailing address for Mr. Pace and other Owens & Minor executives is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. Owens & Minor can also be reached via phone at (804) 723-7000 and via email at truitt.allcott@owens-minor.com. Learn More on Nicholas J. Pace's contact information.
Has Nicholas J. Pace been buying or selling shares of Owens & Minor?: Nicholas J. Pace has not been actively trading shares of Owens & Minor during the last quarter. Most recently, Nicholas J. Pace sold 49,370 shares of the business's stock in a transaction on Wednesday, November 3rd. The shares were sold at an average price of $42.39, for a transaction totalling $2,092,794.30. Learn More on Nicholas J. Pace's trading history.
Who are Owens & Minor's active insiders?: Owens & Minor's insider roster includes Robert Henkel (Director), Jeffrey Jochims (COO), Jonathan Leon (SVP), Andrew Long (CFO), Michael Lowry (SVP), Shana Neal (Insider), Nicholas Pace (EVP), and Edward Pesicka (CEO). Learn More on Owens & Minor's active insiders.
Are insiders buying or selling shares of Owens & Minor?: During the last year, Owens & Minor insiders bought shares 5 times. They purchased a total of 2,718,412 shares worth more than $24,495,308.48. During the last year, insiders at the sold shares 6 times. They sold a total of 42,205 shares worth more than $749,344.10. The most recent insider tranaction occured on April, 9th when Major Shareholder Coliseum Capital Management, L bought 225,000 shares worth more than $1,662,750.00. Insiders at Owens & Minor own 3.6% of the company. Learn More about insider trades at Owens & Minor.
Information on this page was last updated on 4/9/2025.

Nicholas J. Pace Insider Trading History at Owens & Minor

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/3/2021	Sell	49,370	$42.39	$2,092,794.30

Nicholas J. Pace Buying and Selling Activity at Owens & Minor

Owens & Minor Company Overview

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

Today's Range

Now: $6.72

$6.60

$6.97

50 Day Range

MA: $8.32

$6.23

$10.12

2 Week Range

Now: $6.72

$6.07

$25.82

Volume

1,812,824 shs

Average Volume

1,093,982 shs

Market Capitalization

$519.15 million

P/E Ratio

N/A

Dividend Yield